Antibiotic action can be classified as either _______ (kills bacteria) or _______ (inhibits growth).
Antibiotic action can be classified as either bactericidal (kills bacteria) or bacteriostatic (inhibits growth).
Beta-lactams, including _______, _______, _______, and _______, inhibit cell wall synthesis by binding to _______.
Beta-lactams, including Penicillins, Cephalosporins, Carbapenems, and Monobactams, inhibit cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs).
Beta-lactamase inhibitors like _______, _______, _______, and _______ protect the beta-lactam ring from hydrolysis by bacterial beta-lactamases.
Beta-lactamase inhibitors like clavulanate, sulbactam, tazobactam, and avibactam protect the beta-lactam ring from hydrolysis by bacterial beta-lactamases.
Vancomycin is a glycopeptide that binds to the _______ precursor, preventing peptidoglycan polymerization.
Vancomycin is a glycopeptide that binds to the D-Ala-D-Ala precursor, preventing peptidoglycan polymerization.
Daptomycin disrupts cell membrane integrity by creating _______ through calcium-dependent binding, leading to depolarization and cell death.
Daptomycin disrupts cell membrane integrity by creating pores through calcium-dependent binding, leading to depolarization and cell death.
Polymyxins, such as _______ and _______, act as cationic detergents and disrupt membrane integrity by binding to _______ of LPS in gram-negative bacteria.
Polymyxins, such as Colistin and Polymyxin B, act as cationic detergents and disrupt membrane integrity by binding to lipid A of LPS in gram-negative bacteria.
Sulfamethoxazole (SMX) is a competitive inhibitor of _______, blocking PABA incorporation in the folic acid pathway.
Sulfamethoxazole (SMX) is a competitive inhibitor of dihydropteroate synthase, blocking PABA incorporation in the folic acid pathway.
Trimethoprim (TMP) inhibits _______, preventing the production of _______.
Trimethoprim (TMP) inhibits dihydrofolate reductase (DHFR), preventing the production of tetrahydrofolate (THF).
Metronidazole creates reactive oxygen species (ROS) that damage DNA after being reduced by _______.
Metronidazole creates reactive oxygen species (ROS) that damage DNA after being reduced by anaerobic bacteria.
Fluoroquinolones, such as _______, _______, and _______, inhibit DNA gyrase and topoisomerase IV, preventing DNA _______ and replication.
Fluoroquinolones, such as Ciprofloxacin, Levofloxacin, and Moxifloxacin, inhibit DNA gyrase and topoisomerase IV, preventing DNA supercoiling and replication.
Rifampin inhibits mRNA synthesis by binding to the _______, preventing chain elongation.
Rifampin inhibits mRNA synthesis by binding to the RNA polymerase beta-subunit, preventing chain elongation.
Protein synthesis inhibitors target bacterial ribosome subunits, such as the _______ ribosomal subunit, which is bacteriostatic.
Protein synthesis inhibitors target bacterial ribosome subunits, such as the 50S ribosomal subunit, which is bacteriostatic.
Macrolides such as _______, _______, and _______ bind to _______, blocking peptide chain elongation.
Macrolides such as Azithromycin, Erythromycin, and Clarithromycin bind to 23S rRNA, blocking peptide chain elongation.
_______ binds to _______, blocking peptide bond formation.
Clindamycin binds to 23S rRNA, blocking peptide bond formation.
_______ inhibits _______.
Chloramphenicol inhibits peptidyl transferase.
_______ binds to _______, preventing initiation complex formation.
Linezolid binds to 23S rRNA, preventing initiation complex formation.
Aminoglycosides are _______ and bind to _______, causing misreading of mRNA.
Aminoglycosides are bactericidal and bind to 30S rRNA, causing misreading of mRNA.
_______ such as _______ and _______ bind to _______, blocking tRNA binding.
Tetracyclines such as Doxycycline and Tetracycline bind to 30S rRNA, blocking tRNA binding.
For Gram Positive coverage, _______ can be treated with _______ and _______.
For Gram Positive coverage, MSSA can be treated with Nafcillin/Oxacillin and Clindamycin.
_______ can be treated with _______, _______, and _______.
MRSA can be treated with Vancomycin, Daptomycin, and Linezolid.
_______ can be treated with _______ and _______ if sensitive.
Streptococcus pneumoniae can be treated with Penicillin and Aminopenicillins if sensitive.
For Gram Negative coverage, HENS-PECK includes _______, _______, and _______.
For Gram Negative coverage, HENS-PECK includes Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae.
_______ producing Enterobacteriaceae can be treated with _______ such as _______.
ESBL producing Enterobacteriaceae can be treated with Carbapenems such as Meropenem.
For anaerobic coverage, _______ and _______ are effective below the diaphragm.
For anaerobic coverage, Metronidazole and Carbapenems are effective below the diaphragm.
Atypical pathogens like _______ can be treated with _______ and _______.
Atypical pathogens like Mycoplasma pneumoniae can be treated with Fluoroquinolones and Macrolides.
_______ is recommended for tick-borne bacteria such as _______ and _______.
Doxycycline is recommended for tick-borne bacteria such as Borrelia and Rickettsia.
Empiric antibiotic recommendations for common infections are common choices and not _______ requirements by guidelines.
Empiric antibiotic recommendations for common infections are common choices and not absolute requirements by guidelines.
For Community-Acquired Pneumonia (CAP), the recommended treatment is _______.
For Community-Acquired Pneumonia (CAP), the recommended treatment is Beta-Lactam (Ceftriaxone, Ceftaroline) + Macrolide (Azithromycin) or Doxycycline.
In Hospital-Acquired Pneumonia (HAP), treatment includes _______.
In Hospital-Acquired Pneumonia (HAP), treatment includes Vancomycin (MRSA coverage) + Anti-Pseudomonal Beta-Lactam (Piperacillin-Tazobactam, Cefepime, Ceftazidime) or Carbapenem (Meropenem).
For gastrointestinal infections, one treatment option is _______.
For gastrointestinal infections, one treatment option is Carbapenem OR Antipseudomonal PCN + MTZ +/-FQ'S (Ciprofloxacin).
For skin and soft tissue infections caused by MSSA + Strep A, the oral treatments include _______.
For skin and soft tissue infections caused by MSSA + Strep A, the oral treatments include Dicloxacillin, Cephalexin.
For acute cystitis, the recommended treatments are _______.
For acute cystitis, the recommended treatments are TMP-SMX (if local resistance is low), Nitrofurantoin, Fosfomycin.
In bacterial meningitis (community), the treatment is _______ to cover resistant Streptococcus pneumoniae.
In bacterial meningitis (community), the treatment is Ceftriaxone + Vancomycin to cover resistant Streptococcus pneumoniae.
Key adverse drug reactions include _______ from drugs like Cefepime and Carbapenems.
Key adverse drug reactions include Neurotoxicity from drugs like Cefepime and Carbapenems.
For nephrotoxicity, which antibiotics are of concern? _______.
For nephrotoxicity, which antibiotics are of concern? Aminoglycosides, Vancomycin, Polymyxins (Colistin).
Fluoroquinolones and Macrolides are associated with _______.
Fluoroquinolones and Macrolides are associated with QT Prolongation.
Broad-spectrum antibiotics, especially _______, can lead to C. difficile infection.
Broad-spectrum antibiotics, especially Clindamycin, Fluoroquinolones, Carbapenems, Cephalosporins, can lead to C. difficile infection.
A high number of antibiotics can result in _______. Always check on current drugs patients may be on.
A high number of antibiotics can result in high level interactions. Always check on current drugs patients may be on.
Bacteria develop resistance through multiple mechanisms, including _______, _______, _______, and _______.
Bacteria develop resistance through multiple mechanisms, including Reduced Permeability, Increased Efflux Pumps, Decreased Target Binding, and Increased Inactivating Enzymes.
Local antibiotic choice can depend on specific resistance common in those areas, thus it's important to be aware of the _______.
Local antibiotic choice can depend on specific resistance common in those areas, thus it's important to be aware of the Local Antibiogram.
For septic shock with an undifferentiated source, the recommended regimen includes _______ plus _______ or _______.
For septic shock with an undifferentiated source, the recommended regimen includes Piperacillin-Tazobactam plus Vancomycin or Linezolid.
In cases of suspected ESBL or CRE, change the regimen to _______ plus _______ or _______.
In cases of suspected ESBL or CRE, change the regimen to Meropenem plus Polymyxin B or Colistin.
For nosocomial pneumonia, the goals include covering _______, _______, and other _______.
For nosocomial pneumonia, the goals include covering MRSA, Pseudomonas aeruginosa, and other MDR gram-negatives.
Intra-abdominal infections require broad coverage for _______ and _______ bacteria.
Intra-abdominal infections require broad coverage for gram-negative and anaerobic bacteria.
The recommended regimen for severe infections includes _______ (4.5 g IV q8h prolonged infusion) or _______ (2 g IV q8h).
The recommended regimen for severe infections includes Piperacillin-Tazobactam (4.5 g IV q8h prolonged infusion) or Cefepime (2 g IV q8h).
For complicated urinary tract infections, consider _______ for MRSA coverage.
For complicated urinary tract infections, consider Vancomycin for MRSA coverage.
In Central Line-Associated Bloodstream Infections, the goals are to cover _______ such as MRSA and coagulase-negative staph.
In Central Line-Associated Bloodstream Infections, the goals are to cover gram-positive cocci such as MRSA and coagulase-negative staph.
The recommended regimen for meningitis includes _______ 2g IV q12h + _______ AND _______ for Listeria coverage.
The recommended regimen for meningitis includes Ceftriaxone 2g IV q12h + Vancomycin AND Ampicillin for Listeria coverage.
Before initiating antibiotics, it is crucial to obtain appropriate _______ and _______.
Before initiating antibiotics, it is crucial to obtain appropriate cultures and Gram Stain.
For beta-lactams, consider using prolonged or continuous infusions to improve _______.
For beta-lactams, consider using prolonged or continuous infusions to improve T>MIC.
Adjust antibiotic dosing based on _______.
Adjust antibiotic dosing based on renal function.
Once culture data is available, you should _______ to the narrowest spectrum agent appropriate for the identified pathogen.
Once culture data is available, you should de-escalate to the narrowest spectrum agent appropriate for the identified pathogen.
Implement appropriate _______ measures such as abscess drainage and device removal.
Implement appropriate source control measures such as abscess drainage and device removal.
Adhere to institutional _______ guidelines to minimize resistance development.
Adhere to institutional antimicrobial stewardship guidelines to minimize resistance development.
For MSSA (Methicillin-Sensitive Staphylococcus aureus), the preferred antibiotic is _______.
For MSSA (Methicillin-Sensitive Staphylococcus aureus), the preferred antibiotic is Cefazolin.
For MRSA (Methicillin-Resistant Staphylococcus aureus), the preferred antibiotics include _______ and _______.
For MRSA (Methicillin-Resistant Staphylococcus aureus), the preferred antibiotics include Vancomycin and Linezolid.
The preferred antibiotic for Penicillin-Susceptible Streptococcus pneumoniae is _______.
The preferred antibiotic for Penicillin-Susceptible Streptococcus pneumoniae is Penicillin.
For Penicillin-Resistant Streptococcus pneumoniae, the preferred antibiotic is _______.
For Penicillin-Resistant Streptococcus pneumoniae, the preferred antibiotic is Ceftaroline.
For Enterococcus faecalis (Vancomycin-Susceptible), the preferred antibiotics are _______ and _______.
For Enterococcus faecalis (Vancomycin-Susceptible), the preferred antibiotics are Ampicillin and Piperacillin-Tazobactam.
For Vancomycin-Resistant Enterococcus (VRE), the preferred antibiotics include _______ and _______.
For Vancomycin-Resistant Enterococcus (VRE), the preferred antibiotics include Daptomycin and Linezolid.
For Listeria monocytogenes, the preferred antibiotic is _______.
For Listeria monocytogenes, the preferred antibiotic is Ampicillin.
For Enterobacteriaceae, the preferred antibiotics include _______ and _______.
For Enterobacteriaceae, the preferred antibiotics include Ceftriaxone and Piperacillin-Tazobactam.
For ESBL-Producing Enterobacteriaceae, the preferred antibiotics are _______ and _______.
For ESBL-Producing Enterobacteriaceae, the preferred antibiotics are Carbapenems and Ceftazidime-Avibactam.
For Carbapenem-Resistant Enterobacteriaceae (CRE), the preferred antibiotics include _______ and _______.
For Carbapenem-Resistant Enterobacteriaceae (CRE), the preferred antibiotics include Polymyxins and Ceftazidime-Avibactam.
For treating _______, always use _______ of antibiotics due to high mutation potential.
For treating Pseudomonas aeruginosa, always use dual coverage of antibiotics due to high mutation potential.
The preferred antibiotics for _______ are _______, _______, _______ + _______ or _______.
The preferred antibiotics for Pseudomonas aeruginosa are Piperacillin-Tazobactam, Cefepime, Ceftazidime + Aminoglycoside or Fluoroquinolone.
For _______, the main treatment starts with _______.
For Stenotrophomonas maltophilia, the main treatment starts with Doxycycline.
Finding effective antibiotics for _______ is very difficult, so always check the _______.
Finding effective antibiotics for Acinetobacter baumannii is very difficult, so always check the antibiogram.
All anaerobic bacteria will be treated with _______, _______, _______, or _______.
All anaerobic bacteria will be treated with Metronidazole, Carbapenems, Piperacillin-Tazobactam, or Clindamycin.
For atypical coverage, the preferred antibiotics for organisms like _______, _______, and _______ are _______, _______, and _______.
For atypical coverage, the preferred antibiotics for organisms like Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila are Doxycycline, Macrolides, and Fluoroquinolones.
Antibiotic action can be classified as either bactericidal (kills bacteria) or bacteriostatic (inhibits growth).
Beta-lactams, including Penicillins, Cephalosporins, Carbapenems, and Monobactams, inhibit cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs).
Beta-lactamase inhibitors like clavulanate, sulbactam, tazobactam, and avibactam protect the beta-lactam ring from hydrolysis by bacterial beta-lactamases.
Vancomycin is a glycopeptide that binds to the D-Ala-D-Ala precursor, preventing peptidoglycan polymerization.
Daptomycin disrupts cell membrane integrity by creating pores through calcium-dependent binding, leading to depolarization and cell death.
Polymyxins, such as Colistin and Polymyxin B, act as cationic detergents and disrupt membrane integrity by binding to lipid A of LPS in gram-negative bacteria.
Sulfamethoxazole (SMX) is a competitive inhibitor of dihydropteroate synthase, blocking PABA incorporation in the folic acid pathway.
Trimethoprim (TMP) inhibits dihydrofolate reductase (DHFR), preventing the production of tetrahydrofolate (THF).
Metronidazole creates reactive oxygen species (ROS) that damage DNA after being reduced by anaerobic bacteria.
Fluoroquinolones, such as Ciprofloxacin, Levofloxacin, and Moxifloxacin, inhibit DNA gyrase and topoisomerase IV, preventing DNA supercoiling and replication.
Rifampin inhibits mRNA synthesis by binding to the RNA polymerase beta-subunit, preventing chain elongation.
Protein synthesis inhibitors target bacterial ribosome subunits, such as the 50S ribosomal subunit, which is bacteriostatic.
Macrolides such as Azithromycin, Erythromycin, and Clarithromycin bind to 23S rRNA, blocking peptide chain elongation.
For Gram Negative coverage, HENS-PECK includes Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae.
Empiric antibiotic recommendations for common infections are common choices and not absolute requirements by guidelines.
For Community-Acquired Pneumonia (CAP), the recommended treatment is Beta-Lactam (Ceftriaxone, Ceftaroline) + Macrolide (Azithromycin) or Doxycycline.
In Hospital-Acquired Pneumonia (HAP), treatment includes Vancomycin (MRSA coverage) + Anti-Pseudomonal Beta-Lactam (Piperacillin-Tazobactam, Cefepime, Ceftazidime) or Carbapenem (Meropenem).
For gastrointestinal infections, one treatment option is Carbapenem OR Antipseudomonal PCN + MTZ +/-FQ'S (Ciprofloxacin).
For skin and soft tissue infections caused by MSSA + Strep A, the oral treatments include Dicloxacillin, Cephalexin.
For acute cystitis, the recommended treatments are TMP-SMX (if local resistance is low), Nitrofurantoin, Fosfomycin.
In bacterial meningitis (community), the treatment is Ceftriaxone + Vancomycin to cover resistant Streptococcus pneumoniae.
For nephrotoxicity, which antibiotics are of concern? Aminoglycosides, Vancomycin, Polymyxins (Colistin).
Broad-spectrum antibiotics, especially Clindamycin, Fluoroquinolones, Carbapenems, Cephalosporins, can lead to C. difficile infection.
A high number of antibiotics can result in high level interactions. Always check on current drugs patients may be on.
Bacteria develop resistance through multiple mechanisms, including Reduced Permeability, Increased Efflux Pumps, Decreased Target Binding, and Increased Inactivating Enzymes.
Local antibiotic choice can depend on specific resistance common in those areas, thus it's important to be aware of the Local Antibiogram.
For septic shock with an undifferentiated source, the recommended regimen includes Piperacillin-Tazobactam plus Vancomycin or Linezolid.
For nosocomial pneumonia, the goals include covering MRSA, Pseudomonas aeruginosa, and other MDR gram-negatives.
The recommended regimen for severe infections includes Piperacillin-Tazobactam (4.5 g IV q8h prolonged infusion) or Cefepime (2 g IV q8h).
In Central Line-Associated Bloodstream Infections, the goals are to cover gram-positive cocci such as MRSA and coagulase-negative staph.
The recommended regimen for meningitis includes Ceftriaxone 2g IV q12h + Vancomycin AND Ampicillin for Listeria coverage.
Once culture data is available, you should de-escalate to the narrowest spectrum agent appropriate for the identified pathogen.
For MRSA (Methicillin-Resistant Staphylococcus aureus), the preferred antibiotics include Vancomycin and Linezolid.
For Enterococcus faecalis (Vancomycin-Susceptible), the preferred antibiotics are Ampicillin and Piperacillin-Tazobactam.
For Vancomycin-Resistant Enterococcus (VRE), the preferred antibiotics include Daptomycin and Linezolid.
For ESBL-Producing Enterobacteriaceae, the preferred antibiotics are Carbapenems and Ceftazidime-Avibactam.
For Carbapenem-Resistant Enterobacteriaceae (CRE), the preferred antibiotics include Polymyxins and Ceftazidime-Avibactam.
For treating Pseudomonas aeruginosa, always use dual coverage of antibiotics due to high mutation potential.
The preferred antibiotics for Pseudomonas aeruginosa are Piperacillin-Tazobactam, Cefepime, Ceftazidime + Aminoglycoside or Fluoroquinolone.
Finding effective antibiotics for Acinetobacter baumannii is very difficult, so always check the antibiogram.
All anaerobic bacteria will be treated with Metronidazole, Carbapenems, Piperacillin-Tazobactam, or Clindamycin.
For atypical coverage, the preferred antibiotics for organisms like Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila are Doxycycline, Macrolides, and Fluoroquinolones.
Are you sure you want to delete 0 flashcard(s)? This cannot be undone.
Select tags to remove from 0 selected flashcard(s):
Loading tags...